Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 151

1.

Sjogren's Syndrome and TAM Receptors: A Possible Contribution to Disease Onset.

Witas R, Peck AB, Ambrus JL, Nguyen CQ.

J Immunol Res. 2019 May 13;2019:4813795. doi: 10.1155/2019/4813795. eCollection 2019. Review.

2.

What can Sjögren's syndrome-like disease in mice contribute to human Sjögren's syndrome?

Peck AB, Nguyen CQ.

Clin Immunol. 2017 Sep;182:14-23. doi: 10.1016/j.clim.2017.05.001. Epub 2017 May 3. Review.

3.

Oxalate-degrading microorganisms or oxalate-degrading enzymes: which is the future therapy for enzymatic dissolution of calcium-oxalate uroliths in recurrent stone disease?

Peck AB, Canales BK, Nguyen CQ.

Urolithiasis. 2016 Feb;44(1):45-50. doi: 10.1007/s00240-015-0845-6. Epub 2015 Dec 8. Review.

PMID:
26645869
4.

Csf2 and Ptgs2 Epigenetic Dysregulation in Diabetes-prone Bicongenic B6.NODC11bxC1tb Mice.

Garrigan E, Belkin NS, Seydel F, Han Z, Carter J, McDuffie M, Morel L, Peck AB, Clare-Salzler MJ, Atkinson M, Wasserfall C, Davoodi-Semiromi A, Shi JD, Haskell-Luevano C, Yang LJ, Alexander JJ, Cdebaca A, Piliant T, Riggs C, Amick M, Litherland SA.

Genet Epigenet. 2015 Oct 11;7:5-17. doi: 10.4137/GEG.S29696. eCollection 2015.

5.

Involvement of renin-angiotensin-aldosterone system in calcium oxalate crystal induced activation of NADPH oxidase and renal cell injury.

Tsuji H, Wang W, Sunil J, Shimizu N, Yoshimura K, Uemura H, Peck AB, Khan SR.

World J Urol. 2016 Jan;34(1):89-95. doi: 10.1007/s00345-015-1563-y. Epub 2015 May 17.

PMID:
25981400
6.

Activation of the NLRP3 inflammasome in association with calcium oxalate crystal induced reactive oxygen species in kidneys.

Joshi S, Wang W, Peck AB, Khan SR.

J Urol. 2015 May;193(5):1684-91. doi: 10.1016/j.juro.2014.11.093. Epub 2014 Nov 28.

7.

Regulation of macromolecular modulators of urinary stone formation by reactive oxygen species: transcriptional study in an animal model of hyperoxaluria.

Khan SR, Joshi S, Wang W, Peck AB.

Am J Physiol Renal Physiol. 2014 Jun 1;306(11):F1285-95. doi: 10.1152/ajprenal.00057.2014. Epub 2014 Mar 5.

8.
9.
10.

NADPH oxidase as a therapeutic target for oxalate induced injury in kidneys.

Joshi S, Peck AB, Khan SR.

Oxid Med Cell Longev. 2013;2013:462361. doi: 10.1155/2013/462361. Epub 2013 Jun 6. Review.

11.

The important role of T cells and receptor expression in Sjögren's syndrome.

Karabiyik A, Peck AB, Nguyen CQ.

Scand J Immunol. 2013 Aug;78(2):157-66. doi: 10.1111/sji.12079. Review.

12.

Type I interferon receptor deficiency prevents murine Sjogren's syndrome.

Szczerba BM, Rybakowska PD, Dey P, Payerhin KM, Peck AB, Bagavant H, Deshmukh US.

J Dent Res. 2013 May;92(5):444-9. doi: 10.1177/0022034513483315. Epub 2013 Mar 26.

13.

Systems analysis of primary Sjögren's syndrome pathogenesis in salivary glands identifies shared pathways in human and a mouse model.

Horvath S, Nazmul-Hossain AN, Pollard RP, Kroese FG, Vissink A, Kallenberg CG, Spijkervet FK, Bootsma H, Michie SA, Gorr SU, Peck AB, Cai C, Zhou H, Wong DT.

Arthritis Res Ther. 2012 Nov 1;14(6):R238. doi: 10.1186/ar4081.

14.

Apocynin-treatment reverses hyperoxaluria induced changes in NADPH oxidase system expression in rat kidneys: a transcriptional study.

Joshi S, Saylor BT, Wang W, Peck AB, Khan SR.

PLoS One. 2012;7(10):e47738. doi: 10.1371/journal.pone.0047738. Epub 2012 Oct 16.

15.

Rapid oxalate determination in blood and synthetic urine using a newly developed oxometer.

Canales BK, Richards NG, Peck AB.

J Endourol. 2013 Feb;27(2):145-8. doi: 10.1089/end.2012.0438. Epub 2012 Dec 31.

PMID:
22973856
16.

Gene therapy using IL-27 ameliorates Sjögren's syndrome-like autoimmune exocrinopathy.

Lee BH, Carcamo WC, Chiorini JA, Peck AB, Nguyen CQ.

Arthritis Res Ther. 2012 Jul 24;14(4):R172. doi: 10.1186/ar3925.

17.

Transcriptome analysis of the interferon-signature defining the autoimmune process of Sjögren's syndrome.

Peck AB, Nguyen CQ.

Scand J Immunol. 2012 Sep;76(3):237-45. doi: 10.1111/j.1365-3083.2012.02749.x.

18.

Local delivery of AAV2-CTLA4IgG decreases sialadenitis and improves gland function in the C57BL/6.NOD-Aec1Aec2 mouse model of Sjögren's syndrome.

Yin H, Nguyen CQ, Samuni Y, Uede T, Peck AB, Chiorini JA.

Arthritis Res Ther. 2012 Feb 27;14(1):R40. doi: 10.1186/ar3753.

19.

B-cell tolerance defects in the B6.Aec1/2 mouse model of Sjögren's syndrome.

Meng W, Li Y, Xue E, Satoh M, Peck AB, Cohen PL, Eisenberg RA, Luning Prak ET.

J Clin Immunol. 2012 Jun;32(3):551-64. doi: 10.1007/s10875-012-9663-6. Epub 2012 Feb 17.

20.

The current concept of T (h) 17 cells and their expanding role in systemic lupus erythematosus.

Perry D, Peck AB, Carcamo WC, Morel L, Nguyen CQ.

Arthritis. 2011;2011:810649. doi: 10.1155/2011/810649. Epub 2011 Mar 22.

21.

Enzymatic dissolution of calcium and struvite crystals: in vitro evaluation of biochemical requirements.

Thalji NK, Richards NG, Peck AB, Canales BK.

Urology. 2011 Sep;78(3):721.e13-721.e17. doi: 10.1016/j.urology.2011.04.046. Epub 2011 Jul 13.

22.

Sjögren's syndrome: studying the disease in mice.

Delaleu N, Nguyen CQ, Peck AB, Jonsson R.

Arthritis Res Ther. 2011 Jun 13;13(3):217. doi: 10.1186/ar3313. Review.

23.

Gene expression profiling of early-phase Sjögren's syndrome in C57BL/6.NOD-Aec1Aec2 mice identifies focal adhesion maturation associated with infiltrating leukocytes.

Peck AB, Saylor BT, Nguyen L, Sharma A, She JX, Nguyen CQ, McIndoe RA.

Invest Ophthalmol Vis Sci. 2011 Jul 29;52(8):5647-55. doi: 10.1167/iovs.11-7652.

24.

Pathogenic effect of interleukin-17A in induction of Sjögren's syndrome-like disease using adenovirus-mediated gene transfer.

Nguyen CQ, Yin H, Lee BH, Carcamo WC, Chiorini JA, Peck AB.

Arthritis Res Ther. 2010;12(6):R220. doi: 10.1186/ar3207. Epub 2010 Dec 23.

25.

Phenotypic diversity of peripheral blood plasma cells in primary Sjögren's syndrome.

Szyszko EA, Brun JG, Skarstein K, Peck AB, Jonsson R, Brokstad KA.

Scand J Immunol. 2011 Jan;73(1):18-28. doi: 10.1111/j.1365-3083.2010.02475.x.

26.

IL17: potential therapeutic target in Sjögren's syndrome using adenovirus-mediated gene transfer.

Nguyen CQ, Yin H, Lee BH, Chiorini JA, Peck AB.

Lab Invest. 2011 Jan;91(1):54-62. doi: 10.1038/labinvest.2010.164. Epub 2010 Sep 20.

27.

Autoimmunity: limited progress for the patient, despite decades of research.

Delaleu N, Peck AB.

Scand J Immunol. 2009 Nov;70(5):411-4. doi: 10.1111/j.1365-3083.2009.02318.x. No abstract available.

28.

Differential gene expression in the salivary gland during development and onset of xerostomia in Sjögren's syndrome-like disease of the C57BL/6.NOD-Aec1Aec2 mouse.

Nguyen CQ, Sharma A, Lee BH, She JX, McIndoe RA, Peck AB.

Arthritis Res Ther. 2009;11(2):R56. doi: 10.1186/ar2676. Epub 2009 Apr 20.

29.

Unraveling the pathophysiology of Sjogren syndrome-associated dry eye disease.

Nguyen CQ, Peck AB.

Ocul Surf. 2009 Jan;7(1):11-27. Review.

30.

The role of ACAID and CD4+CD25+FOXP3+ regulatory T cells on CTL function against MHC alloantigens.

Saban DR, Cornelius J, Masli S, Schwartzkopff J, Doyle M, Chauhan SK, Peck AB, Grant MB.

Mol Vis. 2008;14:2435-42. Epub 2008 Dec 19.

31.

Differential gene expressions in the lacrimal gland during development and onset of keratoconjunctivitis sicca in Sjögren's syndrome (SJS)-like disease of the C57BL/6.NOD-Aec1Aec2 mouse.

Nguyen CQ, Sharma A, She JX, McIndoe RA, Peck AB.

Exp Eye Res. 2009 Mar;88(3):398-409. doi: 10.1016/j.exer.2008.10.006. Epub 2008 Oct 18.

32.

Identification of possible candidate genes regulating Sjögren's syndrome-associated autoimmunity: a potential role for TNFSF4 in autoimmune exocrinopathy.

Nguyen CQ, Cornelius JG, Cooper L, Neff J, Tao J, Lee BH, Peck AB.

Arthritis Res Ther. 2008;10(6):R137. doi: 10.1186/ar2560. Epub 2008 Nov 25.

33.

Inflammatory caspases are critical for enhanced cell death in the target tissue of Sjögren's syndrome before disease onset.

Bulosan M, Pauley KM, Yo K, Chan EK, Katz J, Peck AB, Cha S.

Immunol Cell Biol. 2009 Jan;87(1):81-90. doi: 10.1038/icb.2008.70. Epub 2008 Oct 21.

34.

Characterization of intraocular immunopathology following intracameral inoculation with alloantigen.

Saban DR, Elder IA, Nguyen CQ, Smith WC, Timmers AM, Grant MB, Peck AB.

Mol Vis. 2008 Mar 26;14:615-24.

35.

Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjögren's syndrome: findings in humans and mice.

Nguyen CQ, Hu MH, Li Y, Stewart C, Peck AB.

Arthritis Rheum. 2008 Mar;58(3):734-43. doi: 10.1002/art.23214.

36.

Autoimmune dacryoadenitis of NOD/LtJ mice and its subsequent effects on tear protein composition.

Doyle ME, Boggs L, Attia R, Cooper LR, Saban DR, Nguyen CQ, Peck AB.

Am J Pathol. 2007 Oct;171(4):1224-36. Epub 2007 Sep 6.

38.
39.

Sjögren's syndrome (SjS)-like disease of mice: the importance of B lymphocytes and autoantibodies.

Nguyen CQ, Cha SR, Peck AB.

Front Biosci. 2007 Jan 1;12:1767-89. Review.

PMID:
17127420
40.

Early pathogenic events associated with Sjögren's syndrome (SjS)-like disease of the NOD mouse using microarray analysis.

Killedar SJ, Eckenrode SE, McIndoe RA, She JX, Nguyen CQ, Peck AB, Cha S.

Lab Invest. 2006 Dec;86(12):1243-60. Epub 2006 Oct 30. Erratum in: Lab Invest. 2007 Apr;87(4):398. Cha, Seunghee R [corrected to Cha, Seunghee]; Killedar, Smruti Y [corrected to Killedar, Smruti J].

41.

Sjögren's syndrome-like disease of C57BL/6.NOD-Aec1 Aec2 mice: gender differences in keratoconjunctivitis sicca defined by a cross-over in the chromosome 3 Aec1 locus.

Nguyen C, Singson E, Kim JY, Cornelius JG, Attia R, Doyle ME, Bulosan M, Cha S, Peck AB.

Scand J Immunol. 2006 Sep;64(3):295-307.

42.

Muscarinic acetylcholine type-3 receptor desensitization due to chronic exposure to Sjögren's syndrome-associated autoantibodies.

Cha S, Singson E, Cornelius J, Yagna JP, Knot HJ, Peck AB.

J Rheumatol. 2006 Feb;33(2):296-306.

PMID:
16465661
43.

Sjögren's syndrome in the NOD mouse model is an interleukin-4 time-dependent, antibody isotype-specific autoimmune disease.

Gao J, Killedar S, Cornelius JG, Nguyen C, Cha S, Peck AB.

J Autoimmun. 2006 Mar;26(2):90-103. Epub 2006 Jan 18.

PMID:
16413168
44.

Role of complement and B lymphocytes in Sjögren's syndrome-like autoimmune exocrinopathy of NOD.B10-H2b mice.

Nguyen C, Cornelius J, Singson E, Killedar S, Cha S, Peck AB.

Mol Immunol. 2006 Mar;43(9):1332-9. Epub 2005 Oct 10.

PMID:
16221495
45.

A dual role for interferon-gamma in the pathogenesis of Sjogren's syndrome-like autoimmune exocrinopathy in the nonobese diabetic mouse.

Cha S, Brayer J, Gao J, Brown V, Killedar S, Yasunari U, Peck AB.

Scand J Immunol. 2004 Dec;60(6):552-65.

46.

Characterization and heterologous expression of the oxalyl coenzyme A decarboxylase gene from Bifidobacterium lactis.

Federici F, Vitali B, Gotti R, Pasca MR, Gobbi S, Peck AB, Brigidi P.

Appl Environ Microbiol. 2004 Sep;70(9):5066-73.

48.

Animal models to study adult stem cell-derived, in vitro-generated islet implantation.

Peck AB, Yin L, Ramiya V.

ILAR J. 2004;45(3):259-67. Review.

PMID:
15229373
49.

In vitro-generation of surrogate islets from adult stem cells.

Peck AB, Ramiya V.

Transpl Immunol. 2004 Apr;12(3-4):259-72. Review.

PMID:
15157920
50.

Pancreatic stem cells: a therapeutic agent that may offer the best approach for curing type 1 diabetes.

Chaudhari M, Cornelius JG, Schatz D, Peck AB, Ramiya VK.

Pediatr Diabetes. 2001 Dec;2(4):195-202.

PMID:
15016187

Supplemental Content

Support Center